KEI comments to USTR and the Trade Policy Staff Committee (TPSC) on Trade related aspects of public goods

https://www.regulations.gov/comment/USTR-2021-0021-0120 Trade related aspects of public goods Submission to USTR and the Trade Policy Staff Committee (TPSC) James Love, KEI March 8, 2022 Introduction One can think of the economy as including both public and private goods, each valued by… Continue Reading

Letter to Ambassador Tai at USTR regarding bilateral and plurilateral trade agreements and COVID 19

USTR-AmbTai-Bilateral-Plurilateal-agreements-3Dec2021 December 3, 2021 Ambassador Katherine Tai Office of the United States Trade Representative Washington, DC Dear Ambassador Tai, On November 18, 2021, Knowledge Ecology International (KEI) provided comments to USTR on three issues that were important for any WTO… Continue Reading

KEI comments on NIH proposed exclusive license to Neogene Therapeutics CRISPR-Engineered T Cell Therapies for the Treatment of Cancer

November 10, 2021 Andrew Burke, Ph.D. Senior Technology Transfer Manager, NCI Technology Transfer Center, Email: andy.burke@nih.gov. Re: Prospective Grant of an Exclusive Patent License: Development and Commercialization of CRISPR-Engineered T Cell Therapies for the Treatment of Cancer to Neogene Therapeutics… Continue Reading

International landscape of molnupiravir patents

(For more resources, please see our page on molnupiravir.) KEI has built a dataset of patents related to molnupiravir based upon a study by Imran et al (2021), the Medicines Patent Pool (MPP) MedsPal database, and our own searches. Our… Continue Reading